Abbott Gains Access To Celera R&D For Infectious Disease Assays
This article was originally published in The Gray Sheet
Executive Summary
U.S. clinical lab evaluation of Celera Diagnostics' analyte-specific reagent hepatitis C test by year-end will be among the early milestones of the Applera unit's R&D and marketing agreement with Abbott